The Top Doctors in Westchester County Offer Expert Care in 2023
pentacel :: Article Creator Sanofi's Pentacel To Compete With GSK's Five-in-one Jab In USA The vaccines unit of Sanofi-Aventis says that US regulators have given the green light to the firm's new five-in-one paediatric jab Pentacel. The vaccines unit of Sanofi-Aventis says that US regulators have given the green light to the firm's new five-in-one paediatric jab Pentacel. The US Food and Drug Administration has approved Sanofi Pasteur's Pentacel which offers protection against diphtheria, tetanus, pertussis, polio and Haemophilus influenza type B. Specifically, Pentacel has been approved for administration as a four-dose series at 2, 4, 6 and 15-18 months of age. Pentacel is the only four-dose diphtheria, tetanus and acellular pertussis (DTaP)-based combination vaccine for use in youngsters in the USA that includes both poliovirus and Hib antigens. The first dose may be given as early as six weeks of age and Sanofi noted that...